Cargando…
Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review
BACKGROUND AND OBJECTIVE: Lineage transformation is a known mechanism of acquired resistance to targeted therapies in non-small cell lung cancer (NSCLC). Transformation to small cell and squamous carcinoma and epithelial-to-mesenchymal transition (EMT) have all been identified as recurrent but rare...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183401/ https://www.ncbi.nlm.nih.gov/pubmed/37197622 http://dx.doi.org/10.21037/tlcr-22-867 |
_version_ | 1785041940745551872 |
---|---|
author | Meador, Catherine B. Piotrowska, Zofia |
author_facet | Meador, Catherine B. Piotrowska, Zofia |
author_sort | Meador, Catherine B. |
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: Lineage transformation is a known mechanism of acquired resistance to targeted therapies in non-small cell lung cancer (NSCLC). Transformation to small cell and squamous carcinoma and epithelial-to-mesenchymal transition (EMT) have all been identified as recurrent but rare events in ALK-positive NSCLC. However, centralized data informing our understanding of the biology and clinical implications of lineage transformation in ALK-positive NSCLC are lacking. METHODS: We performed a narrative review by searching the PubMed and clinicaltrials.gov databases for articles published in English from August, 2007 until October, 2022 and reviewing the bibliographies of key references to identify important literature related to lineage transformation in ALK-positive NSCLC. KEY CONTENT AND FINDINGS: In this review, we aimed to synthesize the published literature describing the incidence, mechanism(s), and clinical outcomes of lineage transformation in ALK-positive NSCLC. Lineage transformation as a mechanism of resistance to ALK TKIs in ALK-positive NSCLC is reported at a frequency of <5%. Available data across molecular subtypes of NSCLC suggest that the process of lineage transformation is likely to be driven by transcriptional reprogramming rather than acquired genomic mutations. Retrospective cohorts including tissue-based translational studies together with clinical outcomes make up the highest level of evidence that exists to inform treatment approach for patients with transfomed ALK-positive NSCLC. CONCLUSIONS: The clinicopathologic features of transformed ALK-positive NSCLC as well as the biologic mechanisms underling lineage transformation remain incompletely understood. Prospective data are needed to develop improved diagnostic and treatment algorithms for patients with ALK-positive NSCLC that undergo lineage transformation. |
format | Online Article Text |
id | pubmed-10183401 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-101834012023-05-16 Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review Meador, Catherine B. Piotrowska, Zofia Transl Lung Cancer Res Review Article BACKGROUND AND OBJECTIVE: Lineage transformation is a known mechanism of acquired resistance to targeted therapies in non-small cell lung cancer (NSCLC). Transformation to small cell and squamous carcinoma and epithelial-to-mesenchymal transition (EMT) have all been identified as recurrent but rare events in ALK-positive NSCLC. However, centralized data informing our understanding of the biology and clinical implications of lineage transformation in ALK-positive NSCLC are lacking. METHODS: We performed a narrative review by searching the PubMed and clinicaltrials.gov databases for articles published in English from August, 2007 until October, 2022 and reviewing the bibliographies of key references to identify important literature related to lineage transformation in ALK-positive NSCLC. KEY CONTENT AND FINDINGS: In this review, we aimed to synthesize the published literature describing the incidence, mechanism(s), and clinical outcomes of lineage transformation in ALK-positive NSCLC. Lineage transformation as a mechanism of resistance to ALK TKIs in ALK-positive NSCLC is reported at a frequency of <5%. Available data across molecular subtypes of NSCLC suggest that the process of lineage transformation is likely to be driven by transcriptional reprogramming rather than acquired genomic mutations. Retrospective cohorts including tissue-based translational studies together with clinical outcomes make up the highest level of evidence that exists to inform treatment approach for patients with transfomed ALK-positive NSCLC. CONCLUSIONS: The clinicopathologic features of transformed ALK-positive NSCLC as well as the biologic mechanisms underling lineage transformation remain incompletely understood. Prospective data are needed to develop improved diagnostic and treatment algorithms for patients with ALK-positive NSCLC that undergo lineage transformation. AME Publishing Company 2023-03-22 2023-04-28 /pmc/articles/PMC10183401/ /pubmed/37197622 http://dx.doi.org/10.21037/tlcr-22-867 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Review Article Meador, Catherine B. Piotrowska, Zofia Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review |
title | Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review |
title_full | Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review |
title_fullStr | Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review |
title_full_unstemmed | Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review |
title_short | Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review |
title_sort | biology and impact of lineage plasticity in alk-positive nsclc: a narrative review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183401/ https://www.ncbi.nlm.nih.gov/pubmed/37197622 http://dx.doi.org/10.21037/tlcr-22-867 |
work_keys_str_mv | AT meadorcatherineb biologyandimpactoflineageplasticityinalkpositivensclcanarrativereview AT piotrowskazofia biologyandimpactoflineageplasticityinalkpositivensclcanarrativereview |